Dermatology Times editorial advisor, Dr. Elaine Siegfried, and adherence expert, Dr. Steven Feldman, talk about the development of Dr. Feldman's Dr. Score physician rating site, patient satisfaction measurements and best practices for using surveys to convey empathy as well as improve your interactions with your patients.
A 65-year-old woman reported that she had stepped on something three years earlier, and it just never healed.
The Food and Drug Administration has approved apremilast (Otezla, Celgene) for the treatment of adult patients with moderate-to-severe plaque psoriasis, the second approval for the drug this year.
A new study suggests the combination therapy of afamelanotide implant and narrowband ultraviolet B (NB-UVB) phototherapy is more effective than NB-UVB therapy alone in treating vitiligo.
Researchers with Dartmouth College have found that genes controlling telomere length of telomeres influence the risk of melanoma.